These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 187507)

  • 1. The use of a multicomponent standard for clostridial vaccines.
    Gray AK
    Dev Biol Stand; 1976; 32():245-50. PubMed ID: 187507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relation between the rabbit potency test and the response of sheep to sheep clostridial vaccines.
    Frerichs GN; Gray AK
    Res Vet Sci; 1975 Jan; 18(1):70-5. PubMed ID: 164058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The titration of clostridial toxoids and antisera in cell culture.
    Knight PA; Burnett C; Whitaker AM; Queminet J
    Dev Biol Stand; 1986; 64():129-36. PubMed ID: 2878845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An international survey of clostridial sera and vaccines.
    Davidson I
    Dev Biol Stand; 1976; 32():3-14. PubMed ID: 187508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clostridium oedematiens: observations on potency assaying.
    Macheak ME
    Dev Biol Stand; 1976; 32():103-12. PubMed ID: 1001824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and evaluation to Clostridium septicum toxoid.
    Kennedy K
    Dev Biol Stand; 1976; 32():123-30. PubMed ID: 1001826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The assay of clostridial vaccines in mice.
    Knight PA; Lucken RN
    Dev Biol Stand; 1976; 32():251-7. PubMed ID: 1001831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Collaborative study for the establishment of a European Pharmacopoeia Biological Reference Preparation for Clostridia antiserum for serological potency testing of veterinary clostridial vaccines.
    Lucken R; Daas A; Behr-Gross ME
    Dev Biol (Basel); 2002; 111():171-80. PubMed ID: 12678238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Standardization of the control technics of Clostridium perfringens vaccine. Use of a reference vaccine].
    Bousicaux A
    Dev Biol Stand; 1976; 32():45-61. PubMed ID: 187511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies on the antigenic structure of anatoxins of Clostridium perfringens, Cl. oedematiens, Cl. septicum and Cl. tetani by determining their fixation properties].
    Kalinichenko NF
    Mikrobiol Zh; 1966; 28(4):75-7. PubMed ID: 4297189
    [No Abstract]   [Full Text] [Related]  

  • 11. Development of monoclonal antibodies suitable for use in antigen quantification potency tests for clostridial veterinary vaccines.
    Hauer PJ; Clough NE
    Dev Biol Stand; 1999; 101():85-94. PubMed ID: 10566780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of Chitosan Nanoparticles in Development of Pentavalent Clostridial Toxoid Vaccine in Terms of Clinical Pathology Elements and Immunological Responses.
    Fathi Najafi M; Rahman Mashhadi M; Hemmaty M
    Arch Razi Inst; 2020 Oct; 75(3):385-395. PubMed ID: 33025779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potency testing of Cl. sordellii bacterin-toxoids by means of a mouse protection test.
    Haas HF
    Dev Biol Stand; 1976; 32():167-72. PubMed ID: 1001830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potency testing of Clostridium septicum bacterins in sheep and laboratory animals.
    Cardella MA; Kolbe DR
    Dev Biol Stand; 1976; 32():115-22. PubMed ID: 1001825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Some problems concerning the assay of Clostridium chauvoei vaccine in laboratory animals.
    Knight PA; Kent J
    Dev Biol Stand; 1976; 32():143-50. PubMed ID: 1001828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Development of in vitro methods for the potency testing of clostridial vaccines].
    Borrmann E; Schulze F; Diller R
    ALTEX; 2001; 18(1):34-6. PubMed ID: 11248848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A hemagglutination inhibition test for control of the quality and effectiveness of highly-purified C. chauvoei toxoid vaccine].
    Roth F; Labarre B; Schmidt-Pannenbecker E
    Berl Munch Tierarztl Wochenschr; 1989 Jan; 102(1):20-5. PubMed ID: 2923618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The International Reference Preparations of Clostridium welchii (C. perfringens) beta and epsilon toxoids.
    Davidson I; Gray AK; Hebert CN; Lesslie IW
    Bull World Health Organ; 1978; 56(4):641-8. PubMed ID: 215337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pathomorphologic changes in animals with experimental gas infection immunized with Cl. perfringens and oedematiens toxoids].
    Pushkarev AA; Sunargulov TS; Mel'nikov VN
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Jan; (1):132-3. PubMed ID: 4375917
    [No Abstract]   [Full Text] [Related]  

  • 20. The standardization of Cl. perfringens antigens and antisera.
    Jansen BC
    Dev Biol Stand; 1976; 32():35-44. PubMed ID: 187510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.